Category: Testosterone Therapy and Hormone Performance Support

Men’s Health, Erectile Function, and Integrative Restoration

Abstract

In this educational post, I present a comprehensive, first-person exploration of erectile dysfunction (ED) through an integrative, evidence-based lens, drawing on current research and clinical practices that combine regenerative medicine, internal medicine, functional medicine, chiropractic neuromusculoskeletal care, and rehabilitation. I explain ED’s multifactorial causes—vascular, neurogenic, hormonal, and psychogenic—and why ED can serve as an early cardiometabolic risk marker. I discuss traditional therapies like PDE5 inhibitors, then take a deeper dive into modern, restorative options including low-intensity extracorporeal shockwave therapy (Li-ESWT) and platelet-rich plasma (PRP) injections. I carefully examine evaluation protocols for hypogonadism (low testosterone), laboratory testing nuances (total versus free testosterone, SHBG, LH, estradiol, prolactin), and monitoring considerations (PSA, hematocrit). I elaborate on peptide-based adjuncts (e.g., hCG, gonadorelin, CJC-1295/ipamorelin, PT-141, BPC-157, TB-500) and their physiologic rationale. Throughout, I highlight how our integrative team at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, brings together chiropractic care, functional medicine, internal medicine oversight, rehabilitation, personal injury care, and patient education under the medical direction of Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933). I share my clinical observations from practice and published research, explain the stepwise reasoning behind each protocol, and show how multidisciplinary care enhances safety, outcomes, and patient experience.

Key takeaways:

• ED is common, increases with age, and often reflects underlying vascular disease; screen for cardiometabolic risk in every ED presentation.
• PDE5 inhibitors can help symptoms but may lead to tolerance; Li-ESWT and PRP target vascular and neural regeneration for restorative impact.
• Testosterone does not directly “cause” ED, but low T can reduce libido and responsiveness to therapies; evaluate hormones comprehensively.
• Integrative care (chiropractic, rehab, functional medicine, internal medicine) supports endothelial health, autonomic balance, pelvic biomechanics, inflammation control, and overall cardiometabolic status.
• Monitoring, shared decision-making, and personalized care plans are essential for safety and sustained results.

---

Introduction to Men’s Health and Erectile Function

I have always approached men’s health as a conversation about vitality—circulation, nerve function, endocrine balance, mental wellbeing, and structural integrity working together. When a patient tells me, “Doc, I’ve got erectile dysfunction—what can I do beyond the blue pill?” my first response is twofold:

• Let’s make sure we understand why this is happening.
• Let’s make sure we are not missing a more serious condition, especially cardiovascular disease.

ED is the inability to attain or maintain an erection sufficient for satisfactory sexual performance. It reduces quality of life, strains relationships, and can be an early marker of systemic vascular disease. The integrative approach we use is designed to restore function at the root level—optimizing blood flow, endothelial health, nerve signaling, hormonal context, mental health, and biomechanics.

In our clinic, I work closely with Dr. Maria Guadalupe Cardenas, MD, who brings over 40 years of internal medicine experience and serves as the Medical Director and Collaborative Physician for our multidisciplinary team at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas. This MD-DC collaboration is foundational to our model of integrative care, ensuring medical oversight, safety, and advanced diagnostics sit comfortably alongside chiropractic and functional medicine strategies.

---

Our Integrative Practice Model in El Paso: Medical Direction and Collaborative Care

I practice as a chiropractor and nurse practitioner with board certification (DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST), and my day-to-day work reflects my firm belief in coordinated, patient-centered care:

• Dr. Maria Guadalupe Cardenas, MD (NPI #1164426749; Texas License #J2933) serves as our Medical Director and Collaborative Physician. She oversees medical protocols, medication safety, laboratory and imaging evaluations, and coordinates care when cardiology, urology, or endocrinology input is needed.
• I lead chiropractic neuromusculoskeletal care and functional medicine assessment, focusing on autonomic balance, pain modulation, biomechanics, pelvic floor and lumbopelvic mechanics, and lifestyle medicine.
• Our rehabilitation team supports neuromuscular retraining, pelvic health therapies, and graded exercise for vascular conditioning.
• We integrate personal injury care principles where trauma, scar patterns, or pelvic/lumbar compromise are components of the ED picture.
• We apply regenerative modalities—low-intensity extracorporeal shockwave therapy (Li-ESWT) and PRP—in carefully screened patients, with internal medicine oversight.

This structure mirrors the modern integrative or injury care clinic, where MDs and DCs collaborate to deliver comprehensive care.

---

Why Erectile Dysfunction Requires a Whole-Person Lens

ED is rarely “just one thing.” As I explain to patients, the penis is a vascular organ governed by neurohormonal and psychogenic regulation, housed within a biomechanical framework (pelvis, lumbar spine, hips) and influenced by systemic inflammation and cardiometabolic health.

• Vascular: Endothelial dysfunction and atherosclerosis reduce nitric oxide (NO) bioavailability, impairing smooth muscle relaxation and arterial inflow.
• Neurogenic: Autonomic imbalance, peripheral neuropathy (e.g., diabetes), pelvic nerve injury (surgery, radiation), and spinal dysfunction can compromise neural signaling.
• Hormonal: Hypogonadism affects libido, mood, energy, and responsiveness to treatments; thyroid, cortisol, and estradiol also modulate sexual function.
• Psychogenic: Depression, anxiety, performance stress, and relationship dynamics profoundly influence desire and arousal.
• Iatrogenic and drug-induced: Antihypertensives, SSRIs, antipsychotics, opioids, and other medications frequently contribute to ED.
• Biomechanical: Pelvic floor hypertonicity, SI joint dysfunction, lumbar facet pain, and hip mechanics can perpetuate pain-avoidance patterns, affect autonomic tone, and reduce sexual function.

When we encounter ED, we’re looking at the whole physiologic network—from cardiometabolic markers to pelvic mechanics—to determine what needs to be restored for erections to happen predictably and comfortably.

---

ED as a Cardiovascular Marker: What I Want Every Patient to Know

If you remember just one thing from this post, let it be this: Erectile dysfunction can be an early sign of cardiovascular disease. The penile arteries are small; they can reveal vascular compromise earlier than coronary symptoms. So, when a patient presents with ED, we screen for cardiometabolic risk—lipids, glycemic status, blood pressure, inflammatory markers, sleep apnea risk, and sometimes advanced vascular testing—in partnership with internal medicine and cardiology when needed. ED is often the first noticeable sign that the vascular system needs attention.

---

Prevalence and Age: What the Numbers Tell Us

ED prevalence climbs with age, driven by cumulative vascular risk, hormonal shifts, medication burden, and chronic disease. Hundreds of millions of men are affected worldwide. While age is a key factor, ED is not “just aging.” It is actionable physiology. There is much we can restore.

---

Pathophysiology of Erection: A Clear, Practical Primer

To choose the right therapies, patients deserve a clear explanation of how erections work.

• Neural triggers: Erotic stimuli and physical touch activate cortical and spinal pathways. Parasympathetic fibers (S2-S4) release NO via neuronal nitric oxide synthase (nNOS) in penile tissue.
• Endothelial response: Shear stress and acetylcholine stimulate endothelial nitric oxide synthase (eNOS) to produce NO, diffusing into smooth muscle of the corpus cavernosum.
• NO-cGMP pathway: NO activates soluble guanylyl cyclase, increasing cyclic GMP (cGMP). cGMP reduces intracellular calcium, causing smooth muscle relaxation, arterial dilation, and venous occlusion of subtunical veins—producing rigidity.
• PDE5 regulation: Phosphodiesterase type 5 degrades cGMP, ending the erection. PDE5 inhibitors (e.g., sildenafil, tadalafil) block this breakdown, prolonging cGMP action.
• Sympathetic and adrenergic tone: Excess sympathetic activity (stress, pain, anxiety) elevates norepinephrine, tightening smooth muscle and impairing erections. Balance is critical.
• Structural integrity: The tunica albuginea’s biomechanical properties, pelvic floor coordination, and absence of pain enable sustained erection and thrusting.
• Hormonal context: Adequate testosterone supports libido, NO synthase expression, PDE5 responsiveness, and mood/energy.

Vascular dysfunction, neuropathy, hormonal imbalance, or psychogenic tension at any step can derail erections.

---

Common Causes and Contributors: From Vascular to Medication Effects

When I assess ED, I use a structured framework:

• Vascular (vasculogenic)
  • Atherosclerosis, endothelial dysfunction, impaired NO signaling
  • Diabetes-related microvascular disease
  • Hypertension-related vascular remodeling
• Neurogenic
  • Peripheral neuropathy (diabetes, B12 deficiency, chemotherapy)
  • Post-surgical or post-radiation nerve injury (e.g., radical prostatectomy)
  • Spinal stenosis, discopathy, or pelvic nerve entrapment
• Hormonal
  • Low testosterone (hypogonadism): impacts libido and PDE5 responsiveness
  • Thyroid dysfunction, hyperprolactinemia, cortisol dysregulation
  • Aromatization and unfavorable T:E2 ratios
• Psychogenic
  • Depression, anxiety, relationship stress, sexual trauma history
  • Performance anxiety and maladaptive autonomic patterns
• Drug-induced
  • Antihypertensives (e.g., beta blockers, thiazides)
  • SSRIs/SNRIs, antipsychotics
  • Opioids and androgen suppression
• Iatrogenic and trauma-related
  • Pelvic surgeries, radiation fibrosis
  • Pelvic fractures, lumbar/pelvic injuries
• Lifestyle and sleep
  • Sedentary behavior, obesity, poor diet, alcohol use
  • Sleep apnea (major factor in testosterone and endothelial dysfunction)
• Biomechanics and pain
  • Pelvic floor hypertonicity or dyssynergia
  • SI joint dysfunction, lumbar facet syndromes, hip pathology

This framework helps us prioritize diagnostics and personalize treatment.

---

Traditional Therapies: PDE5 Inhibitors and Their Limits

PDE5 inhibitors like sildenafil (Viagra) and tadalafil (Cialis) enhance NO-mediated vasodilation by preventing cGMP breakdown. Many patients experience benefits; however:

• Side effects can include flushing, headache, nasal congestion, visual disturbances, back pain (especially with tadalafil), and dyspepsia.
• Drug interactions (e.g., nitrates) can be dangerous.
• Tachyphylaxis: Over time, some men report diminished response, requiring higher doses. This may reflect progressive endothelial dysfunction or underlying disease progression rather than classical receptor desensitization alone.
• They do not regenerate tissue; they amplify an existing pathway that requires baseline endothelial integrity.

Hence, I position PDE5 inhibitors as symptomatic support while we work to restore the vascular and neural substrate.

---

Regenerative and Restorative Options: Low-Intensity Extracorporeal Shockwave Therapy (Li-ESWT)

I often recommend Li-ESWT as a non-invasive modality to improve penile hemodynamics and endothelial function. The mechanism:

• Acoustic waves induce controlled microtrauma that stimulates a healing cascade.
• Upregulation of angiogenic factors like vascular endothelial growth factor (VEGF), endothelial progenitor cell recruitment, and neovascularization.
• Improved endothelial function (eNOS activity), increased smooth muscle content, and enhanced blood flow within the corpus cavernosum.
• Remodeling of microvascular networks supports better filling and rigidity.

Clinical considerations:

• Indications: Vasculogenic ED, especially mild-to-moderate cases; adjunct use after prostate cancer treatment when appropriately timed; diabetic neuropathy-related ED as a supportive therapy.
• Protocols: Typically multiple sessions over several weeks. Exact dosing varies by device and published protocol; our internal medicine oversight ensures safe patient selection.
• Safety: Generally well-tolerated; transient local discomfort or bruising can occur.

At-home options:

• Some patients are interested in handheld acoustic devices for maintenance between in-clinic treatments. While consumer-grade units vary in output and evidence, they can be considered adjuncts with proper guidance. We educate patients on realistic expectations, usage frequency, and safety.

Why it fits integrative practice:

• Li-ESWT targets the vascular root—helping restore endothelial health rather than just masking symptoms—making it a natural complement to functional medicine, chiropractic modulation of autonomic tone, and rehabilitation.

---

Platelet-Rich Plasma (PRP) for Erectile Function

PRP concentrates autologous platelets and growth factors to stimulate tissue repair, angiogenesis, and neuroregeneration. Injected into targeted penile tissues under strict sterile technique, PRP can:

• Promote endothelial and smooth muscle regeneration
• Support nerve healing (especially relevant in diabetic or post-prostatectomy contexts)
• Enhance microcirculation and tissue quality

Physiologic basis:

• Platelet alpha granules release PDGF, VEGF, TGF-β, IGF-1, and other mediators.
• These factors modulate fibroblast activity, collagen remodeling, and neovascularization.

Clinical considerations:

• Indications: Vasculogenic ED, adjuvant care post-prostatectomy (in appropriate windows), Peyronie’s-related tissue remodeling support.
• Safety: Autologous product lowers immunologic risk; minor bruising/swelling possible. Internal medicine oversight ensures patient suitability (platelet counts, anticoagulation considerations).
• Synergy with Li-ESWT: Combining Li-ESWT and PRP often yields better outcomes than either alone, leveraging angiogenic priming and growth factor support.

Rationale within integrative care:

• PRP embodies a regenerative philosophy—supporting intrinsic healing aligned with lifestyle, biomechanics, and cardiometabolic optimization.

---

Combining Li-ESWT and PRP: The Synergistic Rationale

• Li-ESWT primes the microenvironment via microtrauma and angiogenic signaling, increasing receptivity to growth factors.
• PRP delivers concentrated growth factors that capitalize on that primed milieu, enhancing endothelial repair and smooth muscle regeneration.
• Together, they may produce more robust and durable improvements in penile hemodynamics and erectile function.

We personalize sequencing based on patient phenotype, comorbidities, and scheduling preferences—always with metrics and follow-up to gauge response.

---

Post-Prostatectomy and Post-Radiation Patients: Special Considerations

I am frequently asked whether post-prostatectomy or post-radiation patients can be considered for restorative therapies. In collaboration with urology and internal medicine:

• Timing matters. Historical caution favored waiting five years post-cancer therapy before regenerative or hormonal interventions. More recent guidance suggests that 1–2 years may be sufficient for select patients, contingent on oncologic clearance and stable disease markers.
• Li-ESWT and PRP may be considered for neurovascular support once the treating oncologist and urologist agree the window is appropriate.
• Pelvic rehabilitation, nerve gliding, scar mobilization, and autonomic downregulation (e.g., biofeedback, diaphragmatic breathing) are particularly important in this cohort.
• Psychological support and partner-inclusive counseling can be transformative.

We prioritize shared decision-making, clear risk-benefit discussions, and inter-specialty communication.

---

Hormones and Hypogonadism: Clarifying Testosterone’s Role

A critical nuance: Low testosterone does not directly “cause” ED in most cases, but hypogonadism frequently diminishes libido, energy, mood, and the physiological responsiveness of erectile tissue to NO and PDE5 inhibitors.

Symptoms suggestive of low testosterone:

• Reduced libido, erectile difficulty, fatigue, depressed mood, decreased initiative
• Reduced morning erections, slow recovery from exercise, decreased lean mass
• Possible gynecomastia or increased abdominal adiposity

Physical and lab considerations:

• Obesity often lowers sex hormone-binding globulin (SHBG), which can render total testosterone “normal” despite functional deficiency. Hence, free testosterone assessment is essential in obese patients.
• A practical viewpoint I share with patients: Your free testosterone reflects the biologically active hormone available to tissues. If SHBG is low or high, total T can mislead.

---

Laboratory Evaluation: Getting It Right the First Time

When I evaluate possible hypogonadism, I follow a methodical pathway:

• Total testosterone: Draw in the morning (typically 7–10 a.m.). Repeat on a separate day for confirmation, as values fluctuate.
• Free testosterone: Especially in obesity, metabolic syndrome, or when total T is borderline or inconsistent with symptoms.
• SHBG: To interpret discrepancies between total and free T.
• LH and FSH: Differentiate primary (testicular) from secondary (hypothalamic-pituitary) hypogonadism.
  • Low T with high LH/FSH suggests primary testicular failure.
  • Low T with low/normal LH/FSH suggests central hypogonadism—consider prolactin and pituitary scrutiny.
• Prolactin: Elevated levels may indicate a prolactinoma or medication effects (e.g., antipsychotics).
• Estradiol (E2): Especially with gynecomastia or obesity to assess aromatization and T E2 ratio dynamics.
• Thyroid panel: Thyroid dysfunction can drive fatigue, mood changes, and sexual symptoms.
• Cortisol or HPA-axis assessment: Selectively, especially with sleep disruption, central adiposity, or chronic stress.
• PSA and digital rectal exam: For men considering testosterone therapy, with age- and risk-based screening.

Cutoffs and interpretation:

• The American Urological Association considers total testosterone <300 ng/dL as a biochemical threshold for hypogonadism in the presence of symptoms. I always treat the patient, not just the number—symptom context is essential.

---

Testosterone Therapy: Indications, Targets, and Monitoring

When we initiate testosterone replacement therapy (TRT) in appropriate candidates:

• Goals: Alleviate symptoms (energy, libido, mood), improve lean mass and bone density, enhance glycemic control in insulin-resistant individuals, and support sexual function responsiveness.
• Target range: A pragmatic window is often 450–600 ng/dL for total testosterone, recognizing that individual symptom relief may occur at different levels and that levels can overshoot and require dose adjustments.
• Monitoring:
  • Hematocrit/hemoglobin: Watch for erythrocytosis; adjust dose or dosing interval if hematocrit rises excessively.
  • PSA and prostate health: Regular surveillance, particularly in older men or those with prostate risk factors.
  • Lipids, glucose, blood pressure: Assess cardiometabolic impacts.
  • Sleep apnea screening: TRT can exacerbate obstructive sleep apnea; untreated OSA should be addressed before or during TRT.
  • Estradiol: Adjust aromatization risk; optimize T:E2 balance. Excessive suppression of E2 can impair endothelial health and libido.

Special cautions:

• Post-cardiac event: Avoid initiating TRT within 3–6 months of an acute coronary syndrome without cardiology input.
• Prostate cancer history: Shared decision-making with urology; evolving evidence and careful monitoring can allow TRT in select patients after appropriate oncologic clearance.

Why TRT can help ED:

• By improving libido and mood, and by enhancing NO synthase expression and PDE5 inhibitor responsiveness, TRT can make erections more achievable. However, TRT is not the primary ED treatment in most men—it is an adjunct that optimizes the hormonal milieu for other therapies to work better.

---

Questionnaires and Communication: Opening the Door for Men

Many men are reluctant to initiate conversations about ED. In my clinic, we use validated questionnaires to invite dialogue:

• Androgen deficiency screening (e.g., ADAM-like tools) focusing on libido and erectile strength
• Sexual Health Inventory for Men (SHIM) to quantify erectile function
• Mood and sleep screeners to capture depression/anxiety and sleep apnea risk

These tools create a comfortable on-ramp to meaningful, private conversations.

---

Peptide-Based Adjuncts: Where They Fit and Why

Peptides can support physiologic pathways relevant to sexual function, tissue repair, and energy. In our practice, we apply them thoughtfully, after hormonal evaluation and cardiometabolic screening.

• hCG (human chorionic gonadotropin): Mimics LH to stimulate Leydig cells and endogenous testosterone production. May be used with or without TRT to preserve fertility or as a fertility-friendly alternative. Side effects can include increased estradiol, fluid retention, or mood changes; we monitor E2 and symptoms.
• Gonadorelin: A GnRH analog that can stimulate LH/FSH secretion from the pituitary, supporting endogenous testosterone and spermatogenesis; particularly useful when preserving fertility is a priority.
• CJC-1295 with ipamorelin: Supports pulsatile growth hormone release; patients often report improved sleep, recovery, body composition, and vitality. Indirectly, better sleep and reduced adiposity can benefit sexual function and endothelial health.
• PT-141 (bremelanotide): Centrally acting melanocortin receptor agonist that increases sexual desire and can improve erectile function independent of NO pathways—useful in PDE5 non-responders or where NO is compromised. Dose titration is key due to nausea risk; we start low and go slow.
• BPC-157 and TB-500: Regenerative adjuncts that may support angiogenesis, tissue repair, and nitric oxide signaling. While not ED-specific, they fit a tissue-healing paradigm—especially when pelvic or musculoskeletal injuries are present.

We place peptides in the context of a comprehensive plan; they are not magic bullets, but they can be valuable tools when physiology and safety are respected.

---

Sleep Apnea and ED: Why I Screen Aggressively

Obstructive sleep apnea (OSA) is an underrecognized driver of ED and low testosterone. Intermittent hypoxia:

• Damages endothelial function
• Disrupts nocturnal testosterone rhythms
• Increases sympathetic drive (counterproductive for erections)

TRT can worsen untreated OSA by relaxing upper airway musculature. Therefore:

• We screen ED patients for OSA risk (snoring, witnessed apneas, morning headaches, hypertension, daytime sleepiness).
• When appropriate, we refer for sleep studies and initiate CPAP or other therapies.
• Addressing OSA can dramatically improve energy, libido, metabolic health, and erectile function.

---

Integrative Chiropractic Care: Where the Spine, Pelvis, and Autonomics Meet Sexual Function

As a chiropractor and clinician in functional medicine, I often see the interplay between pain, autonomic stress, and sexual function:

• Pain and sympathetic overdrive: Chronic pain elevates sympathetic tone, releasing norepinephrine that tightens smooth muscle in cavernous tissue—counteracting erection.
• Pelvic floor dynamics: Hypertonic pelvic floors can contribute to erectile and ejaculatory dysfunction. Biofeedback, breathing, manual therapy, and targeted exercises can normalize tone.
• Lumbopelvic mechanics: SI joint dysfunction, lumbar facet irritation, or hip mobility restrictions can produce antalgic posture and pelvic floor guarding, reducing sexual comfort and performance.
• Neural facilitation: Manual therapy, spinal manipulation, and neurodynamic techniques can modulate nociception, improve autonomic balance, and reduce myofascial trigger patterns that perpetuate sexual dysfunction.

When paired with cardiometabolic optimization and regenerative therapies, chiropractic supports the neuromusculoskeletal foundations of erectile function.

Clinical observations from my work:

• Patients with low back pain and hypertonic pelvic floors often report improved erections after a course of lumbopelvic adjustments, soft tissue release, and pelvic floor downtraining, especially when we add diaphragmatic breathing and graded exposure to sexual activity without pain.
• Restoring hip extension and addressing anterior pelvic tilt can reduce pelvic floor strain and improve comfort and rigidity during intercourse.

References to my clinical perspective and ongoing educational contributions can be found on my clinic site and professional profile:

• https://chiromed.com/
• https://www.linkedin.com/in/dralexjimenez/

---

Functional Medicine Foundations: Inflammation, Metabolism, and Vascular Health

ED improves when we address the roots of endothelial dysfunction:

• Nutrition: Emphasize Mediterranean-style or DASH-pattern diets rich in polyphenols, omega-3s, nitrate-rich vegetables (beets, leafy greens), and low in refined sugars. This supports NO production, reduces oxidative stress, and improves lipid profiles.
• Glycemic control: Hyperglycemia damages microvasculature and nerves. We optimize A1c, fasting insulin, and postprandial responses with dietary strategies, activity, and sometimes pharmacotherapy in collaboration with Dr. Cardenas.
• Lipids and blood pressure: Dyslipidemia and hypertension impair endothelial function. We personalize treatment plans—nutrition, exercise, and medication when indicated.
• Exercise: Aerobic and resistance training increase endothelial NO, improve insulin sensitivity, and reduce visceral adiposity. We tailor programs for safety and adherence.
• Stress and sleep: Mind-body practices, cognitive behavioral strategies, and sleep hygiene reduce sympathetic overload and restore hormonal rhythms.
• Micronutrients: We evaluate zinc, vitamin D, B12, and general nutrient status where indicated; deficiencies can impact testosterone synthesis and nerve health.

By repairing the vascular terrain, we enhance the effectiveness of PDE5 inhibitors, Li-ESWT, PRP, and TRT.

---

Medication Review and Deprescribing Opportunities

Because many medications can contribute to ED, our internal medicine oversight is invaluable:

• Antihypertensives: We consider switching from agents with higher ED risk to alternatives with neutral/beneficial profiles when clinically appropriate.
• SSRIs/SNRIs: For patients with SSRI-induced dysfunction, options include dose adjustments, drug holidays (with psychiatric guidance), switching agents, or adding adjuncts like bupropion. PT-141 may offer benefit in select cases.
• Opioids: These suppress the HPG axis and libido. We explore pain management alternatives—chiropractic, rehabilitation, interventional pain approaches, and non-opioid pharmacology.
• Antipsychotics: Collaboration with psychiatry is essential; sexual function can be prioritized alongside mental health stability.

We never make unilateral medication changes; we coordinate with the prescribing physician and the patient.

---

Evaluating ED: A Stepwise Clinical Pathway

When a man presents with ED at our clinic, our integrative pathway looks like this:

1. History and questionnaires
   • Sexual function (onset, severity, nocturnal/morning erections, relationship factors)
   • Cardiometabolic risk (diabetes, hypertension, dyslipidemia, family history)
   • Medications and substances (alcohol, tobacco, recreational drugs)
   • Sleep (screen for OSA)
   • Pain and biomechanics (low back, pelvis, hips)
   • Mood and stress
2. Physical exam
   • Vital signs, BMI, waist circumference
   • Cardiovascular and neurologic screening
   • GU exam when indicated
   • Musculoskeletal: lumbopelvic assessment, pelvic floor tone, hip mobility
3. Labs and diagnostics
   • Testosterone (total and free), SHBG, LH/FSH, prolactin, estradiol
   • Metabolic panels: A1c, fasting glucose, lipids, hs-CRP, kidney/liver function
   • PSA per age/risk
   • Thyroid panel
   • Sleep study if OSA risk elevated
   • Consider penile Doppler ultrasound in select vasculogenic cases (urology)
4. Initial plan
   • Address cardiometabolic risks
   • Consider PDE5 inhibitors for symptom relief
   • Initiate lifestyle and chiropractic/rehab interventions
   • Plan for Li-ESWT and/or PRP if appropriate
   • Discuss hormonal therapy when indicated and safe
5. Monitoring and iterative care
   • Track symptom scores (SHIM), energy, libido, and partner feedback
   • Reassess labs (hematocrit, PSA, T/E2 as appropriate)
   • Adjust protocols for response and tolerability
   • Coordinate with cardiology/urology/endocrinology as needed

This structure promotes safety, personalization, and meaningful outcomes.

---

Integrating Personal Injury Care When Trauma Is Part of the Story

Men who present after accidents—motor vehicle collisions, work injuries, or sports trauma—may have:

• Pelvic fractures, pubic symphysis dysfunction, or SI joint instability
• Lumbar disc injury or stenosis with nerve involvement
• Residual pain that disrupts sexual function and creates fear-avoidance patterns

Our personal injury experience helps us:

• Restore biomechanics and reduce pain through chiropractic and rehab
• Guide graded return to sexual activity with positions and pacing that minimize pain
• Introduce mind-body pacing to reduce anticipatory anxiety and sympathetic activation

When the body feels safe and pain is controlled, erectile function often improves.

---

Psychogenic Factors, Counseling, and Partner Involvement

ED frequently carries a psychogenic component—sometimes primary, often secondary to initial physical dysfunction. We:

• Normalize the experience: ED is common and treatable.
• Encourage partner-involved discussions to reduce secrecy and shame.
• Refer to counseling when trauma, relationship conflict, or significant performance anxiety is present.
• Teach nervous system regulation: breathwork, progressive muscle relaxation, and mindfulness to downshift sympathetic tone.
• Consider centrally acting agents like PT-141 in select cases resistant to peripheral pathways.

Healing is faster when the mind and relationship ecosystem are part of the plan.

---

Putting It Together: Example Care Pathways

Scenario 1: Mild-to-moderate vasculogenic ED in a 52-year-old with hypertension and dyslipidemia

• Internal medicine adjusts antihypertensives to reduce ED risk
• Nutrition and exercise plan; consider statin or alternative lipid strategy as appropriate
• PDE5 inhibitor for immediate support
• Li-ESWT course with home pelvic floor relaxation exercises and chiropractic care
• Evaluate testosterone status; if low with symptoms, discuss TRT with monitoring
• Results: Improved SHIM scores, better blood pressure and lipids, reduced reliance on high PDE5 doses

Scenario 2: Post-prostatectomy patient 18 months out, cleared by urology

• Shared decision-making re: Li-ESWT and PRP sequence
• Pelvic rehab (nerve gliding, scar mobilization), autonomic regulation practices
• Consider PT-141 if NO-pathway limited response
• Monitor progress with internal medicine and urology collaboration
• Results: Gradual return of erectile function, improved confidence and relationship satisfaction

Scenario 3: Obese 45-year-old with SSRI-induced sexual dysfunction and untreated sleep apnea

• Sleep study → CPAP initiation; possible psychiatric consultation for antidepressant strategy
• Functional nutrition, resistance training; weight reduction goals
• Free testosterone assessment; manage hypogonadism if present
• Consider PT-141 low-dose for desire, Li-ESWT if vascular findings
• Chiropractic and rehab to reduce low back pain and sympathetic tone
• Results: Energy and libido increase, better erections, mood stability preserved

---

Safety, Ethics, and Shared Decision-Making

We anchor our care in safety and patient autonomy:

• Transparent discussion of benefits, risks, alternatives
• Appropriate intervals for lab monitoring and oncology/cardiology coordination
• Avoiding overpromising; setting realistic expectations and timelines
• Respecting patient values and preferences in choosing therapies

---

The Role of Education and Self-Care

My patients do better when they understand their bodies and have agency. We emphasize:

• Daily walking and resistance training to boost NO and insulin sensitivity
• Nitrate-rich vegetables and polyphenols for endothelial support
• Sleep regularity, CPAP adherence when prescribed
• Stress regulation techniques to normalize autonomic tone
• Honest partner communication to reduce performance pressure

Small, consistent actions compound to restore sexual health.

---

Evidence, Guidelines, and Evolving Frontiers

ED management draws from urology, cardiology, endocrinology, sleep medicine, rehabilitation, and integrative health research. Key points reflected in current literature:

• ED as a vascular risk marker: Screening for cardiometabolic disease is essential.
• PDE5 inhibitors: Efficacious for many; consider tolerance and side effects.
• Li-ESWT and PRP: Growing evidence supports restorative benefits in vasculogenic ED, with combination approaches showing enhanced outcomes.
• Hypogonadism: Symptom-driven diagnosis with biochemical confirmation; TRT helps selected patients and requires careful monitoring.
• Sleep apnea: Treatment improves sexual and hormonal health; TRT requires caution in untreated OSA.
• Psychogenic factors: Behavioral therapies and centrally acting agents (PT-141) can help, especially in complex or refractory cases.

Our clinic stays current by engaging with new research and participating in continuing education—balancing innovation with safety.

---

How MD-DC Collaboration Elevates Care

I cannot overstate the value of having Dr. Maria Guadalupe Cardenas, MD, as our Medical Director and Collaborative Physician:

• She ensures medical rigor in our protocols, from lab interpretation to medication safety.
• She coordinates with specialists when deeper cardiac or oncologic questions arise.
• She enhances patient trust and provides continuity, especially for patients with complex medical histories.

My chiropractic and functional medicine perspective dovetails with her internal medicine expertise. Together, we craft personalized plans that address the heart of the problem and the whole person.

---

Practical Tips for Patients Starting the Journey

• Be candid: Your story helps us help you. ED is common—we’re here to listen, not judge.
• Expect a workup: Blood tests and sometimes imaging are part of getting answers.
• Think beyond pills: Restorative therapies and lifestyle changes can produce deeper, more lasting improvements.
• Prioritize sleep and stress: These are not side issues—they are central to hormonal and vascular health.
• Involve your partner: Healing is easier together.

---

What I’ve Learned from Practice

Over the years, several themes keep showing up:

• When we treat ED as a vascular and systemic issue first, outcomes improve.
• Patients who embrace lifestyle change alongside regenerative therapies maintain gains longer and need fewer medications.
• Pelvic floor and spinal mechanics matter more than most people think—addressing them often unlocks progress.
• Communication and trust create adherence; adherence creates results.

You can read more about our clinical philosophy and community education efforts at:

• https://chiromed.com/
• https://www.linkedin.com/in/dralexjimenez/

---

Conclusion: From Symptom Relief to True Restoration

Erectile dysfunction is not a life sentence—it’s a call to action. By identifying the root contributors and addressing them with modern, evidence-based, integrative care, we can restore function and confidence. Our multidisciplinary model in El Paso brings internal medicine oversight, chiropractic neuromusculoskeletal care, functional medicine, rehabilitation, and regenerative therapies together for safe, personalized, and effective care.

If ED brought you here, let it also guide you toward better heart health, stronger energy, and deeper connection. We’re ready to walk that path with you.

---

References

• American Urological Association. (n.d.). Guidelines on the evaluation and management of testosterone deficiency.
• Burnett, A. L., Nehra, A., Breau, R. H., Culkin, D. J., Faraday, M. M., Hakim, L. S., Heidelbaugh, J. J., Khera, M., Kirkby, E., Miner, M. M., Nelson, C. J., Sadeghi-Nejad, H., Shindel, A. W., & Montague, D. K. (2018). Erectile dysfunction: AUA guideline. The Journal of Urology.
• Corona, G., Rastrelli, G., Maseroli, E., Forti, G., Maggi, M. (2015). Cardiovascular risk associated with erectile dysfunction. European Heart Journal.
• Gruenwald, I., Appel, B., Vardi, Y. (2013). Low-intensity shockwave therapy in vascular erectile dysfunction. Therapeutic Advances in Urology.
• Khera, M., Bhattacharya, R. K., Blick, G., Kushner, H., Nguyen, D., Miner, M. (2011). Testosterone therapy and cardiovascular outcomes. The Journal of Sexual Medicine.
• Levine, L. A., & Rybak, J. (2011). Trauma, pelvic surgery, and ED: Pathophysiology and management. The Journal of Sexual Medicine.
• Porst, H., Burnett, A., Brock, G., Ghanem, H., Giuliano, F., Glina, S., Hellstrom, W., Montorsi, F., & Sharlip, I. (2013). The Princeton III Consensus recommendations for the management of ED and cardiovascular disease. The Journal of Sexual Medicine.
• Ramasamy, R., et al. (2019). Platelet-rich plasma therapy for erectile dysfunction: Mechanisms and evidence. Sexual Medicine Reviews.
• Reisman, Y., et al. (2017). Low-intensity extracorporeal shockwave therapy for erectile dysfunction: Clinical evidence review. The World Journal of Men’s Health.
• Shindel, A. W., & Lue, T. F. (2007). Sexual dysfunction in men with diabetes and metabolic syndrome. The Journal of Sexual Medicine.
• Tan, R. S., Pu, S. J. (2002). Obstructive sleep apnea and erectile dysfunction. The Aging Male.
• Vardi, Y., Appel, B., Jacob, G., Massarwi, O., Gruenwald, I. (2010). Can low-intensity extracorporeal shockwave therapy improve erectile function?. European Urology.
• Yafi, F. A., Jenkins, L., Albersen, M., Corona, G., Isidori, A. M., Goldfarb, S., Maggi, M., & Hellstrom, W. J. G. (2016). Erectile dysfunction. Nature Reviews Disease Primers.